Anti-LINGO-1: All You Need to Know

admin avatar

by admin |

Share this article:

Share article via email

news_8_-40

Recently, Biogen released results from its Phase 2 acute optic neuritis (AON) RENEW trial which tested Anti-LINGO-1. Learn more about this results here.

So what isĀ Anti-LINGO-1?

According to the MS Society,Ā Anti-LINGO-1 (also known as BIIB033) is a treatment in development by the pharmaceutical company Biogen which is currently being tested in people with optic neuritis, relapsing-remitting MS, and secondary progressive MS.

LINGO is a protein found in nerve cells and myelin-making cells called oligodendrocytes. Blocking the activity of this protein with an antibody called anti-LINGO-1 has been shown to result in myelin repair in animal models of MS.

Anti-LINGO-1 itā€™s taken as an intravenous infusion.

Read the Anti-LINGO-1 latest news here:Ā https://bit.ly/1ZJzxrV